Accent Therapeutics' Series A Round

Accent Therapeutics raised a round of funding on May 18, 2018.

Accent Therapeutics is a biopharmaceutical company developing oncology-focused, small molecule therapies in the emerging field of epitranscriptomics. This field of biology encompasses post-transcripti…

Articles about Accent Therapeutics' Series A Round: